Metabolic bone disease describes a diverse group of disorders of bone metabolism, most commonly caused by abnormalities of minerals (such as calcium or phosphorous) or vitamin D. Allogenic ...

A new review on zoonotic infections—diseases transmitted by animals—in the Canadian Arctic provides timely guidance to clinicians as the region experiences heightened global interest as well ...

Brain polyglucosan bodies (PBs) cause fatal neurodegenerative diseases including Lafora disease and adult polyglucosan body disease (ABPD), for which treatments, biomarkers, and good understanding of ...

While this mechanism has so far only been shown in mice, further studies will investigate how autophagy regulates metabolism in both mouse and human-based models of neurodegenerative diseases.

After so many years of learning how microbes work, researchers are now digitally recreating their inner workings ... serve as an atlas for the metabolism of complex diseases.

Furthermore, the correlations between NOX and ferroptosis, based on energy metabolism, are preliminarily discussed. Further discoveries of these mechanisms might promote the development of novel ...

Severe metabolic liver disorders and unmet medical needs that are glycogen storage diseases type I (GSDI ... Canepari and Cantore explore the use of gene transfer and genome editing to correct this ...

Members of this Division are motivated to advance the way we manage patients and to improve health for those with disease of the liver and gastrointestinal tract." Professor Mark Thursz Head of ...

Glycogen storage disease (GSD) refers to a group of rare genetic conditions that affect how the body stores and breaks down glycogen. The most common type is type I, also called von Gierke disease.